Evaluation of the BRAINDEX Brain Monitor in Cardiac Surgery, Interventional Comparative Study

NCT ID: NCT06594198

Last Updated: 2025-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-09

Study Completion Date

2025-03-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to show the concordance of the SctO2 values of the ARGOS platform with the standard SctO2 values (comparative study with platform INVOS, Medtronic).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SctO2 values from ARGOS and INVOS will be resampled every 30 seconds. The two signals will then be resynchronized and compared on a sample-by-sample basis using a Pearson correlation test. Bias and agreement limits will be assessed using Bland \& Altmann graphs. This test will be carried out for the entire duration of the recording.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Brain Monitor Anaesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single-centre, prospective, interventional clinical study
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

One center and 40 patients

Monitor the values of 3 brain parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor.

Group Type EXPERIMENTAL

Cerebral monitor

Intervention Type DEVICE

The study procedure consists of monitoring the values of 3 cerebral parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor. These 3 parameters will be recorded and compared after the intervention with 3 parameters considered as standard: SctO2 measured by the INVOS 7100 cerebral oximeter, the bispectral index (BIS) measured by the BIS monitor and the ANI measured by the MDoloris monitor. These 3 reference parameters are once again usually monitored and recommended for all cardiac surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cerebral monitor

The study procedure consists of monitoring the values of 3 cerebral parameters: SctO2, bcSEF and ANI measured by the ARGOS sensor. These 3 parameters will be recorded and compared after the intervention with 3 parameters considered as standard: SctO2 measured by the INVOS 7100 cerebral oximeter, the bispectral index (BIS) measured by the BIS monitor and the ANI measured by the MDoloris monitor. These 3 reference parameters are once again usually monitored and recommended for all cardiac surgery.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient, male or female, over 18 years of age
* Patient scheduled for cardiac surgery with programmed extracorporeal circulation (ECC)
* Patient with no history of scalp injury or or skin diseases
* Patient with an Euroscore 2 of less than 7%.
* Patient affiliated or entitled to a social assurance

Exclusion Criteria

* Weight under 40 kg
* Frontal surface too small to allow application of SctO2, BIS electrodes on the same hemifront
* Patient with severe, unbalanced hypertension
* Measurement of systolic blood pressure (SBP) \> 180 mm Hg and/or diastolic blood pressure (DBP) \> 110 mm Hg
* Patients undergoing emergency surgery
* Patient with chronic renal failure, with glomerular filtration \< 30 ml/min/1.73m², or requiring renal transplantation or requiring renal transplantation
* Patient with left ventricular ejection fraction \< 40%
* Patient with a history of ischemic stroke
* Patients with preoperative sepsis
* Patient requiring noradrenaline infusion noradrenaline infusion in the 24 hours prior to surgery
* Patient with preoperative uni or bilateral carotid stenosis bilateral carotid stenosis \> 50%.
* Protected patient: adult under guardianship, curatorship or legal protection, deprived of liberty by judicial or administrative decision.
* Pregnant, parturient or breast-feeding women.
* Patients hospitalized without consent.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinique de la Sauvegarde

OTHER

Sponsor Role collaborator

Braindex

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinique de la Sauvegarde

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00125

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Personal BP - CAI Study
NCT06492746 RECRUITING NA